Member Info for curlly

Well well well that's a great turnaround

Onwards and upwards i say

Could we end blue

Mk cap so low for that last rns lets hope we start going up after the dip

Why the sudden flurry of buys?

Let's hope as there's a steady stream of buys coming in

I thought we would have seen more buys with all the talk at the weekend

So why did you not buy when the price was £3,85

Here is the news released today

TIDMPRM

RNS Number : 2669O

Proteome Sciences PLC

02 October 2023

2 October 2023

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Launch of Commercial Single Cell Proteomics Services

Proteome Sciences plc is pleased to announce the launch of SysQuant(R)

SCP, the commercial service for single cell proteomics using the

power of its TMTpro(TM) isobaric labelling reagents. Where more

traditional approaches can measure a few 10s of proteins on each

cell using antibody labelling, SysQuant(R) SCP can identify more

than 1,000 proteins in each study of 576 single cells and provides

novel insights into individual cell biology and heterogeneity.

Proteome Sciences is one of the first commercial providers of such

studies which are expected to significantly improve the performance

of drug development across multiple diseases including cancer,

neurodegeneration, respiratory and cardiac health, and metabolic

disorders. Whilst in its infancy, the field of single cell proteomics

is expected to grow rapidly as drug developers look to integrate

single cell genomic data with knowledge of protein changes. At

the same time, the complexity of the process along with the need

to purchase and maintain costly equipment represents a significant

barrier to entry.

The SysQuant(R) SCP pipeline generates and analyses quantitative

mass spectrometry data to reveal subtle changes not only in individual

cells but also within sub-populations of that same main cell type.

This data will greatly improve understanding of the biological

drivers of heterogeneity and evolution in the contexts of disease

and response to therapy, which will offer new therapeutic and diagnostic

targets for personalized medicine.

Commenting on the launch of SysQuant(R) SCP, Dr. Ian Pike Chief

Scientific Officer stated:

"This is an important step for Proteome Sciences as we have adapted

cutting-edge techniques developed in academia to make them available

to the pharmaceutical and biotechnology industries through SysQuant(R)

SCP. We have built a robust platform that will provide customers

with transformational data enabling a deeper understanding of disease

biology and how drugs are interacting with their targets. SysQuant(R)

SCP studies are highly complementary to our established workflows

performed on larger samples and open up a new customer base needing

access to this valuable novel single cell information."

Dr. Mariola Soehngen, Chief Executive Officer commented:

"We are pleased to be one of the first CROs providing single cell

proteomics to our customers. The launch of SysQuant(R) SCP is part

of our growth strategy along with the opening of a US facility

in San Diego. We believe that broadening our range of services

and incr

Why is the rns not showing this morning

And what about the delayed sell 08:06:43 2.9555 234,570 Unknown* 2.80 3.00 6,933

That's a biggy

Yes we should be higher on that rns

Yes a dip in earnings don't deserve a 30% drop in share price

I was expecting better, not expecting a dip in earnings

It's nice to see a bit of blue for a change

And what about all the large sells going through

Contrarian123 The market seems to disagree with you and i would say anyone sorting at this price are taking a big risk.

Day after day so many late delayed buys and with a bit of a tree shake this morning i still think we have a long way to go

Here comes the big delayed buys again

A lot of late buys coming in